IndiaTickerUpdates - Bliss GVS Pharma LimitedNSE · exchange filing · zip
Source filing Company dossier
Bliss GVS Pharma
NSE:BLISSGVS · ISIN INE416D01022
- Close
- ₹456 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bliss GVS Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Bliss GVS Pharma Ltd - 506197 - Pre-Offer Advertisement & Corrigendum to Detailed Public StatementBSE · exchange filing · pdf
Source filing Cessation - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Bliss GVS Pharma LimitedNSE · exchange filing · zip
Source filing Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-CessationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend 2018-2019 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) AuthorityBSE · corporate action · pdf
Source filing Updates - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Intimation Of Recommendations By The Committee Of Independent Directors ('IDC') Pursuant To Regulation 26(7) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011BSE · exchange filing · pdf
Source filing Updates - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · corporate action · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Letter Of Offer Dated July 18, 2026 Received From SBI Capital Markets LimitedBSE · exchange filing · pdf
Source filing Updates - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Updates - Bliss GVS Pharma LimitedNSE · exchange filing · zip
Source filing Public Announcement-Open Offer - Bliss GVS Pharma LimitedNSE · exchange filing · zip
Source filing General Updates - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Updates - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Archived filing Shareholders meeting - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Archived filing Bliss GVS Pharma Ltd - 506197 - Proceedings Of 41St Annual General Meeting Of Bliss GVS Pharma LimitedBSE · exchange filing · pdf
Source filing Shareholders meeting - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Archived filing Bliss GVS Pharma Ltd - 506197 - Contact Details Of Kmps For Reporting Of Material Events To Stock ExchangesBSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Allotment of Securities - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Bliss GVS Pharma LimitedNSE · financial results · pdf
Archived filing Appointment - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Appointment - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Bliss GVS Pharma LimitedNSE · exchange filing · zip
Source filing Resignation - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, July 03, 2026BSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Trading Window - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing Bliss GVS Pharma Ltd - 506197 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Bliss GVS Pharma LimitedNSE · exchange filing · pdf
Source filing